People Living with HIV in UK

HIV Testing Programs


                        
         
          Scientific Federation proudly invites all the participants from all over the world to attend 2nd International Conference & Expo on HIV & AIDS during Sep 17-18, 2018 in Toronto, Canada.

           According to the 2011 census, there were 989,628 people of black African background in England and Wales. 479,799 were men and 509,829 were women. The population of black African represents about 1.8% of the resident population of England. The Public Health of England situational report of 2015 on HIV indicated that the number of people living with HIV in the UK continues to increase and the number living with undiagnosed HIV remains high. It was estimated that 103700 people were living with HIV in the UK in 2015, of which about 17% were undiagnosed and did not know about their HIV status. The report also showed that about 40% of people diagnosed with HIV in 2015 were diagnosed late. The number of people living with HIV aged over 50 has been increasing and there has been a 2% decrease in testing at sexual health clinics over the past year. The report indicated that 54,100 people had acquired HIV through heterosexual sex. More than one in five was unaware of their HIV infection. A higher proportion of those diagnosed with HIV was living outside London. It is a fact that if someone has a late diagnosis, it is more likely that the virus will have already seriously damaged his or her immune system. 51% black African suffered in this way according to PHE 2014 statistics.

          Across Luton, HIV rates among men who have sex with other men (MSM) as well as heterosexual black African men and women continue to go up. In Luton there are 622 Luton residents that are HIV positive accessing care, of which 470 are seen and treated in Luton, 409 are of Black African origin (PHE, 2016). I am an enthusiastic and a staunched member of a black African and Caribbean Church as are many of my fellow countrymen. The leading Pastor is a very influential figure in these communities. His role is pivotal in encouraging HIV/AIDS patients to take prescribed medications as well as participating in prayer. Sadly, the recent investigation by health agencies and the media exposed major concerns that some Pastors are advising their church members not to take an HIV test and to refrain from taking anti-retroviral therapy (ART) or Pre-Exposure Prophylaxis (PrEP). Some Pastors prefer to teach that prayer alone will provide a cure. Those who adhered to this ignorant approach were not well served by their Pastors. In 2011, the BBC reported that Evangelical Christians Pastors claims that prayer alone could cure HIV/AIDS caused three deaths.

          To make matters worse, a significant number of infections remain undiagnosed, which once again underlines the importance of testing. Black African men and women are advised to have an HIV test and a regular HIV and sexually transmitted infections (STI) screen if having unprotected sex with new or casual partners. However, the uptake in HIV testing remains relatively low, partly because of complacency about HIV/AIDS as a major global health concern, but also because of the age-old stigma around the virus that we haven’t yet managed to completely shake. While diseases like cancer are addressed and discussed openly, HIV is often a topic that people avoid talking about it*956, which leads to a culture of shame and misinformation. Many are so afraid of contracting HIV that they avoid testing, choosing not to know their status. Many are too afraid to tell their partners that they are HIV positive, in case they are rejected and shamed. HIV is a virus. It doesn’t define anyone and doesn’t contribute or take away anything from an individual’s worth. It is a health problem that we all need to discuss and tackle together.

          Research evidence suggested that the stigma and the discrimination associated with HIV are serious burdens for many black African people living with HIV in the UK. A national strategy is needed to address HIV- related stigma, including within the NHS, and this should also be reflected in local initiatives, especially in areas of high HIV prevalence. It is really important to adopt effective anti-stigma approaches to include improved information on HIV treatment and prognosis, engagement with faith communities in anti-stigma and anti-discrimination work, as well as addressing wider racism associated with HIV.

          In fact, there is a need for an expanded and a scaled up HIV testing programmes across the target communities to reduce undiagnosed infection and late diagnosis. It is very important that HIV is diagnosed early so that people can start treatment, look after their own health and take steps to ensure that they don’t pass the virus on. Delay in diagnosis increases the risk of complications and death. Most people living with HIV infection if diagnosed early can be well managed and lead full and healthy lives. Early testing and diagnosis of HIV reduce treatment costs: £12,600 per annum per patient, compared with £23,442 with a later diagnosis (PHE, 2015).

          Take Action Now and U Test 4 Life project was designed to aim at reducing new infection rate of HIV and promoting early diagnosis through setting up testing clinic in the high risk communities, promoting and creating awareness of HIV /AIDS, challenging the stigma and discrimination associated with HIV /AIDS in churches and communities through mass campaign and education, signposting people to various GUM Clinics and other HIV Support services in the community for effective treatment and medication, increasing capacity building of services and treatment to people living with HIV and their families in the high risk communities in Luton. It took place in the high-risk communities in Luton -Bedfordshire in the East of England where the majority of the black African people are populated especially in the High Town ward of Luton. The High Town community is considered as red light zones because the HIV infection is high due to women indulge in the sex trade, men have sex with men, people engage in drugs due to poverty.

          HIV-AIDS-2018 will provide the excellent opportunities for the researchers, scientists, professors, delegates and students from all over the world exchange information on HIV-AIDS which contains plenary sessions, keynote speeches, poster, and oral presentations on HIV-AIDS On Emerging area on Immunology, Microbiology, Infection&Imunnity, Public Health, Infectious Diseases, Virology, Pathology, Psychology, Biochemistry, Epidemiology, Gynecology, Global Health, and Population Health.

To Know More about Hiv-Aids-2018Click Here

1 comments:

Prof. Nassiri as an OCM in our Conference

HIV Community & Planning



                        
          Scientific Federation proudly invites all the participants from all over the world to attend 2nd International Conference & Expo on HIV & AIDS during Sep 17-18, 2018 in Toronto, Canada.

          Prof. Nassiri is an OCM in our Conference and he is a former Associate Dean of Global Health at the Michigan State University (MSU).  He also served as MSU director of Institute of International Health.  He is currently a faculty member of the departments of Pharmacology and Toxicology, and, Family and Community Medicine, and, lecturer in Global Health, Infectious Diseases, and Tropical Medicine.  He currently works on international public health issues relating to chronic diseases and has expertise in global health. He has made contributions in various fields of medical sciences including clinical investigation and health education. On the basis of his extensive experience and expertise in chronic infectious diseases including HIV/AIDS, TB as well as antimicrobial resistance and human gut microbiome, he developed clinical research programs in Brazil, South Africa, Haiti, Dominican Republic and Mexico. He had served as editorial board member for the Journal of HIV and AIDS Review.  He is currently an editorial board member for AIDS Patient Care and STDs, and International Journal of Global Health.  Prof. Nassiri has delivered seminar presentations on Tropical Medicine, HIV/AIDS, TB, Global Health and public health interventions in numerous national and international conferences and workshops. He is internationally recognized for his work in the areas of building effective international partnerships particularly in global health, community health, clinical care capacity building, and technical assistance mechanism. He has developed academic and research partnership programs with Federal University of Para Institute of Tropical Medicine in Belem, Brazil.

          AIDS remains a public health and social challenge threatening the global population.  There are approximately 36.5 million people currently living with HIV and tens of millions of people have died of AIDS-related complications since the beginning of the epidemic. The greatest prevalence and incidence remains in Eastern and southern Africa with 19 million (52%) affected.  While new cases have been reported in all regions of the world, approximately two-thirds are in sub-Saharan Africa, with 46% of new cases in Eastern and Southern Africa.  In the endemic regions outside the western countries, many people living with HIV or at risk for HIV do not have access to prevention, care, and treatment.  HIV impacts households, communities, and the development and economic growth of nations.

          The number of HIV-positive patients receiving treatment has increased to more than 18 million in 2016.  However, significant gaps exist.  While studies show declines in new infections among adults observed earlier in the epidemic, the incidence is now rising particularly in China and India.  HIV epidemic has led to a resurgence of tuberculosis (TB), particularly in Africa.  TB is a leading cause of death for people with HIV worldwide.  In 2015, approximately 11% of new TB cases occurred in people living with HIV.  Interestingly, between 2004 and 2014 TB deaths in people living with HIV declined by 32%, largely due to the scale-up of joint HIV/TB services (The Global HIV/AIDS Epidemic, Kaiser Family Foundation.  January 2017). 

          From our experience of HIV preventive work in the Dominican Republic, effective prevention strategies include behavior change programs, condom use, HIV testing, blood supply safety, harm reduction efforts for injecting drug users, and male circumcision (WHO and CDC recommendations). Additionally, recent research has shown that providing HIV treatment to people with HIV significantly reduces the risk of transmission to their HIV-negative partners. Pre-exposure antiretroviral prophylaxis (PrEP) has also been shown to be an effective HIV prevention strategy in individuals at high risk for HIV infection.  In 2015, the WHO recommended PrEP as a form of prevention for high-risk individuals in combination with other prevention methods.  Additionally, in 2016, the U.N. Political Declaration on HIV/AIDS stated PrEP research and development should be accelerated.  Numerous studies suggest that prevention should be based upon “evidenced-based knowledge of epidemic” directed to tailor the prevention and control measures to the local context and epidemiology, and using a combination of sustainable strategies.  However, access to prevention remains limited especially in resource-limited counties, and there have been renewed calls for the strengthening of prevention efforts. 

          In the United States, new HIV infections are becoming rare.  When they do occur, every person, regardless of age, gender, race/ethnicity, sexual orientation, gender identity, or socio-economic circumstance, will have access to quality, life-extending care, free from stigma and discrimination.  The goals of the US national HIV/AIDS prevention and control strategies are to reduce new HIV infections, to allow increased access to care and improved outcomes among People Living with HIV, to reduce HIV-related disparities and health inequities among the minority and migrant populations, and to achieve a more coordinated HIV national response (National HIV/AIDS Strategy, the White House, July 2012). 

          The Dublin Declaration on Partnership to Fight HIV/AIDS in Europe and Central Asia has dramatically impacted the regional response to the epidemic. The monitoring process of the Declaration has provided valuable insight on the progress of HIV prevention and control by countries and where improvements in national programs must be made to reduce the number of new infections and improve the quality of life for people living with HIV.  

          HIV-AIDS-2018 will provide the excellent opportunities for the researchers, scientists, professors, delegates and students from all over the world exchange information on HIV-AIDS which contains plenary sessions, keynote speeches, poster, and oral presentations on HIV-AIDS On Emerging area on Immunology, Microbiology, Infection&Imunnity, Public Health, Infectious Diseases, Virology, Pathology, Psychology, Biochemistry, Epidemiology, Gynecology, Global Health, and Population Health.



To Know More about Hiv-Aids-2018: Click Here

0 comments: